FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster
© Reuters. FILE PHOTO: Family doctor Vera Maria Soditt vaccinates a patient at her home with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine in Cologne, Germany, March 28, 2021. REUTERS/Thilo Schmuelgen
(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer (NYSE:PFE) Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.
More Stories
Oil inches higher as Middle East tensions heat up
© Reuters. Army soldier miniatures and stock graph are seen in this illustration taken October 9, 2023. REUTERS/Dado Ruvic/Illustration/File Photo...
Asian stocks rise before US CPI; Japan’s Nikkei extends rally
. JP225 +1.88% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully to: + Add another position...
SEC approves spot Bitcoin ETFs
. SEC approves spot bitcoin ETFs BTC/USD +1.76% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully...
Google lays off hundreds in Assistant, hardware, engineering teams
© Reuters. The Google logo is seen on the Google house at CES 2024, an annual consumer electronics trade show,...
US SEC approves bitcoin ETFs in watershed for crypto market
© Reuters. FILE PHOTO: FILE PHOTO: U.S. Securities and Exchange Commission logo and representations of cryptocurrency are seen in this...
Amazon has not offered remedies to EU concerns over iRobot deal
© Reuters. FILE PHOTO: The logo of Amazon is seen at the company's logistics centre in Boves, France, October 6,...